Clinical research is a primary pathway for developing new treatments, medications, and technologies capable of transforming the lives of thousands. However, for these advances to truly benefit the entire population, it is essential that studies reflect the diversity found across the country.

In a country of continental proportions like Brazil, ensuring the participation of people from different regions, socioeconomic backgrounds, cultural characteristics, and healthcare access realities is a challenge, but also a scientific, ethical, and social necessity.

It is precisely on this topic that the Instituto Projeto Cura presents another piece of content from the project Walking with Confidence, an initiative created to expand public access to qualified information about clinical research, empower patients, and promote knowledge about studies conducted in Brazil.

‍

Why does geographic representation matter?

Every clinical trial seeks to produce reliable scientific evidence regarding the safety and efficacy of new treatments. For this evidence to reflect the reality of the population that may use these therapies in the future, it is important that participants represent the diversity existing in the country.

When people from different regions, age groups, ethnic backgrounds, socioeconomic conditions, and cultural contexts participate in studies, researchers can better understand how a treatment may respond across different population profiles.

This diversity strengthens the scientific quality of research, increases the robustness of the evidence produced, and contributes to new medications being used with greater safety and effectiveness.

Furthermore, more representative research expands opportunities for the population to access innovative therapies while they are still in clinical development, helping to reduce inequalities in access to health innovation.

‍

Equity is also part of clinical research

Promoting more inclusive research goes beyond inviting participants from different regions. It is necessary to reduce the barriers that hinder or prevent many people from participating.

These factors mean that many people are not even aware that clinical trials are underway or are unable to evaluate whether they wish to participate in them.

Promoting equity means creating fairer opportunities for different population groups to learn about, understand, and consider participating in clinical trials, always on a voluntary and ethical basis that respects their rights.

‍

More inclusive research benefits all of society

When clinical trials better reflect the diversity of the Brazilian population, the benefits reach far beyond the participants themselves.

Research with greater representation contributes to:

• Develop more effective treatments for different patient profiles
• Produce more consistent scientific evidence that is representative of the Brazilian reality
• Improve the safety assessment of new medications across different populations
• Strengthen public policies based on scientific evidence
• Expand access to health innovation in different regions of the country

In other words, the more inclusive clinical research is, the greater its ability to generate knowledge that benefits society as a whole.

‍

Representation is science. Equity is a commitment.

Including diverse participant profiles is not just a methodological aspect of clinical research. It is also an ethical commitment to a more democratic, accessible science that is aligned with the real needs of the population.

Building more representative studies requires the joint involvement of researchers, research institutions, sponsors, healthcare professionals, civil society organizations, public managers, and the population itself.

By expanding participation opportunities and reducing access inequalities, we strengthen not only the quality of research but also public trust in science and health innovation.

Clinical research helps save lives, and the more people who can be part of this process, the greater the possibilities for developing treatments capable of benefiting Brazilians from different regions and backgrounds.

‍

Caminhando com Confiança promotes accessible, high-quality information

This content is part of the Caminhando com Confiança project, developed by the Instituto Projeto Cura with the goal of increasing public access to qualified information about clinical research, strengthening patient autonomy, and promoting greater knowledge about studies conducted in Brazil.

The initiative seeks to provide society with reliable and accessible information about clinical research, contributing to a clearer understanding of how new treatments are developed and what rights and precautions are involved in participating in clinical studies.

The project is aligned with Good Clinical Practice, Law No. 14.874/2024, the General Data Protection Law (LGPD), and national and sectoral benchmarks, including the Interfarma Guide.

The Caminhando com Confiança campaign is supported by GSK, reinforcing a commitment to the dissemination of evidence-based information, ethics, and transparency.

Understanding how clinical research works is an important step toward building trust, reducing misinformation, and strengthening more informed health decisions.

By promoting qualified and accessible information, the Caminhando com Confiança project seeks to bring patients, families, and society closer to the world of clinical research, reinforcing its role in the advancement of oncology and in building a future with more treatment possibilities.

‍

The Projeto Cura Institute

The Projeto Cura Institute is a non-profit organization established in 2016, dedicated to raising public awareness about the importance of clinical research for advancing cancer treatment in Brazil and Latin America.

With a mission to increase awareness and foster research to combat cancer, the Institute works by promoting high-quality information, social mobilization, and investment in academic studies.

Guided by the values of knowledge management, awareness, mobilization, social responsibility, and transparency, the Projeto Cura Institute believes that tackling cancer requires joint efforts between society, science, and various sectors, expanding access to information, education, and health innovation.

Follow the content from the Projeto Cura Institute and join this journey of information, knowledge, and hope.